The latest research have revealed that green tea contains a compound
that shows great promise for the development of drugs to treat two types of tumours
and a deadly congenital disease. The discovery is the result of research led by
Principal Investigator, Dr. Thomas Smith at The Donald Danforth Plant Science
Center and his colleagues at The Children’s Hospital of Philadelphia. Their
findings are published in the recent article,"Green Tea Polyphenols
Control Dysregulated Glutamate Dehydrogenase In Transgenic Mice By Hijacking
The ADP Activation Site” in The Journal of Biological Chemistry. Read original article here
